التداول الداخلي في الأسهم الأمريكية | أبلغت CeriBell عن 10 عمليات تداول داخلية للشركة في 5 مارس

5 March 2026, CeriBell (CBLL) disclosed 10 company insider transaction records. Director Chao Xingjuan bought 23.6k shares on 3 March 2026.

【Recent Insider Transactions】

【Company Information】

CeriBell, Inc. was incorporated in Delaware on 29 August 2014. They are a medical technology company in the commercial stage, focused on changing the diagnosis and management of patients with serious nervous system diseases. They develop the Ceribell system, a novel point-of-care electroencephalogram (“EEG”) platform specifically designed to address unmet needs in acute care settings. The Ceribell system combines proprietary, highly portable, quickly deployable hardware with complex artificial intelligence (“AI”)-driven algorithms to enable rapid diagnosis and continuous monitoring of patients with nervous system disorders. Leveraging the power of artificial intelligence, the Ceribell system makes EEG easier to obtain and enables continuous monitoring, allowing clinicians to diagnose and manage patients at risk for seizures more quickly and accurately in acute care settings, thereby improving patient outcomes and the economic benefits for hospitals and payers.